Our products

Protocol for a verification of bank account details

Important

Every time upon receiving an invoice, we suggest verifying bank account details on Polpharma API webpage.
Please type manually api.polpharma.com/bank-account into your browser to access the details, checking for the correct spelling.

Please, be aware

  • Official domains used by Polpharma are polpharma.com or polpharma.pl
  • Be aware of potential impersonators using URLs similar to Polpharma but not original ones (like polphrama.com or similar).
  • In case of any discrepancies or suspicions, please contact the sales representative or Polpharma Security Department at security@polpharma.com
  • If you receive information about the change of bank account details only by e-mail, or asking to change the bank details for a specific invoice,
    please inform your Polpharma sales representative urgently.
  • We advise you not to click on any links in e-mails.

Changes to bank account

Any changes to bank account numbers happen only in special circumstances, and the information must be presented
within a proper timeframe to the customer by the combination of:

  1. e-mail from polpharma.com or polpharma.pl domain
  2. post mail
  3. videoconference with a Polpharma sales representative

Bank details:

Zakłady Farmaceutyczne Polpharma
Pelplinska 19
83-200 Starogard Gdanski
Poland

Currency: USD

Account number:
16103011170000000001017206
IBAN: PL PL16103011170000000001017206
Account name: POLPHARMA SA BIEZACY
Bank’s Code: 10301117
Bank’s name:
Bank Handlowy w Warszawie S.A.
Bank’s head office:
ul. Senatorska 16, 00-923 Warszawa
Country: Poland
Swift Code: CITIPLPX

Currency: EUR

Account number:
80103011170000000001017218
IBAN: PL 80103011170000000001017218
Account name:
POLPHARMA SA POMOCNICZY
Bank’s Code: 10301117
Bank’s name: Bank Handlowy w Warszawie S.A.
Bank’s head office:
ul. Senatorska 16, 00-923 Warszawa
Country: Poland
Swift Code: CITIPLPX

Polpharma’s strategic investment in HPAPI facility
We have launched an investment in a specialized facility
for the R&D and Production of highly active substances
with an OEL value of 10 ng/m3 (OEB 6).

The HP API investment includes separate process
laboratories (PDL), analytical laboratories (ADL)
with the possibility of performing Quality Control
analyses, and a GMP kilo-lab production line with
volume up to 1.5 kg with potential volume increase.

LEARN MORE